DE69825173D1 - Doppelschichtige kapsel von ungesättigten fettsäuren oder deren derivate und verfahren zu deren herstellung - Google Patents

Doppelschichtige kapsel von ungesättigten fettsäuren oder deren derivate und verfahren zu deren herstellung

Info

Publication number
DE69825173D1
DE69825173D1 DE69825173T DE69825173T DE69825173D1 DE 69825173 D1 DE69825173 D1 DE 69825173D1 DE 69825173 T DE69825173 T DE 69825173T DE 69825173 T DE69825173 T DE 69825173T DE 69825173 D1 DE69825173 D1 DE 69825173D1
Authority
DE
Germany
Prior art keywords
derivatives
double
production
fatty acids
unsaturated fatty
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69825173T
Other languages
English (en)
Other versions
DE69825173T2 (de
Inventor
Hideki Sunohara
Ryosei Kamaguchi
Toshio Kozaki
Masatomo Yoshikado
Junko Higuchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Morishita Jintan Co Ltd
Original Assignee
Morishita Jintan Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Morishita Jintan Co Ltd filed Critical Morishita Jintan Co Ltd
Application granted granted Critical
Publication of DE69825173D1 publication Critical patent/DE69825173D1/de
Publication of DE69825173T2 publication Critical patent/DE69825173T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
DE69825173T 1997-10-30 1998-10-26 Doppelschichtige kapsel von ungesättigten fettsäuren oder deren derivate und verfahren zu deren herstellung Expired - Lifetime DE69825173T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP29855297 1997-10-30
JP29855297 1997-10-30
PCT/JP1998/004819 WO1999022719A1 (fr) 1997-10-30 1998-10-26 Preparation de capsule contenant un acide gras insature ou un derive de celui-ci, et procede de fabrication

Publications (2)

Publication Number Publication Date
DE69825173D1 true DE69825173D1 (de) 2004-08-26
DE69825173T2 DE69825173T2 (de) 2005-08-25

Family

ID=17861221

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69825173T Expired - Lifetime DE69825173T2 (de) 1997-10-30 1998-10-26 Doppelschichtige kapsel von ungesättigten fettsäuren oder deren derivate und verfahren zu deren herstellung

Country Status (7)

Country Link
US (1) US6531150B1 (de)
EP (1) EP1025842B1 (de)
JP (1) JP4309045B2 (de)
KR (1) KR100569319B1 (de)
CA (1) CA2307776C (de)
DE (1) DE69825173T2 (de)
WO (1) WO1999022719A1 (de)

Families Citing this family (92)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9901809D0 (en) * 1999-01-27 1999-03-17 Scarista Limited Highly purified ethgyl epa and other epa derivatives for psychiatric and neurological disorderes
AU2878801A (en) * 1999-10-01 2001-05-10 Natco Pharma Limited An improved pharmaceutical composition and a process for its preparation
JP5196693B2 (ja) * 2001-05-02 2013-05-15 小川香料株式会社 非架橋ゼラチンカプセルの皮膜架橋防止方法
NO20021592D0 (no) 2002-04-04 2002-04-04 Fmc Biopolymer As Polysakkaridkapsler og fremgangsmåte ved fremstilling derav
WO2004084870A1 (en) * 2003-03-28 2004-10-07 Sigmoid Biotechnologies Limited Solid oral dosage form containing seamless microcapsules
US7790362B2 (en) 2003-07-08 2010-09-07 Accumetrics, Inc. Controlled platelet activation to monitor therapy of ADP antagonists
US20070243632A1 (en) 2003-07-08 2007-10-18 Coller Barry S Methods for measuring platelet reactivity of patients that have received drug eluting stents
JP2005041818A (ja) * 2003-07-23 2005-02-17 Takeda Chem Ind Ltd コーティング製剤
US7134978B2 (en) * 2003-07-28 2006-11-14 Sagittarius Life Science Corporation Seamless BB paintball
WO2005048993A2 (en) * 2003-11-14 2005-06-02 Alza Corporation Minimization of drug oxidation in drug irradiated excipients formulations
JP2012051945A (ja) * 2003-11-21 2012-03-15 Wakunaga Pharmaceut Co Ltd カプセル剤、カプセル剤の製造方法およびカプセル皮膜
JP4913340B2 (ja) * 2003-11-21 2012-04-11 湧永製薬株式会社 カプセル剤
US20050152969A1 (en) * 2004-01-08 2005-07-14 Chiprich Timothy B. Colored liquid-filled soft capsules and method of manufacture thereof
US20050238739A1 (en) * 2004-04-23 2005-10-27 Thomas Nisslein Composition comprising a combination of calcium, cimicifugae racemosae rhizoma and vitamin D and its use as a pharmaceutical in conditions or disorders associated with or resulting from calcium deficiency or as a nutritional supplement
JP4694145B2 (ja) * 2004-05-17 2011-06-08 株式会社 メドレックス 経口腸溶性製剤
US20060039966A1 (en) * 2004-08-12 2006-02-23 Miller Bruce A Jr Dosage delivery apparatus for improving user acceptance of oral supplements and medicaments and methods for manufacturing same
EP1802287A2 (de) * 2004-09-27 2007-07-04 Sigmoid Biotechnologies Limited Minikapsel-formulierungen
JP4860164B2 (ja) * 2005-02-25 2012-01-25 第一三共株式会社 シームレスカプセル
RU2007139819A (ru) * 2005-03-29 2009-05-10 МакНЕЙЛ-Пи-Пи-Си, ИНК. (US) Композиции с гидрофильными лекарствами в гидрофобной среде
US7205115B2 (en) * 2005-04-28 2007-04-17 Accumetrics, Inc. Method and system for stabilization of arachidonic acid for use in platelet function assay
JP2009502841A (ja) * 2005-07-26 2009-01-29 グラクソ グループ リミテッド 脂質をベースにした製剤の腸溶性ポリマー中へのカプセル化
WO2007019883A1 (en) * 2005-08-16 2007-02-22 Symrise Gmbh & Co. Kg Chocolate coated spherical filled capsules
WO2007103186A2 (en) 2006-03-03 2007-09-13 Fmc Corporation Method and apparatus for the preparation of capsules
JP5628480B2 (ja) * 2006-03-09 2014-11-19 グラクソスミスクライン エルエルシー 医薬成分を含有するコーティングカプセル
US8784886B2 (en) * 2006-03-09 2014-07-22 GlaxoSmithKline, LLC Coating capsules with active pharmaceutical ingredients
JP4968820B2 (ja) * 2006-05-31 2012-07-04 三生医薬株式会社 カプセル
EP2046305A2 (de) * 2006-06-26 2009-04-15 Valpharma S.A. Pharmazeutische zusammensetzung zur oralen verabreichung von omega-polyen-fettsäuren
CA2683407C (en) 2007-04-04 2016-09-20 Sigmoid Pharma Limited Pharmaceutical cyclosporin compositions
JP2010527285A (ja) * 2007-04-26 2010-08-12 シグモイド・ファーマ・リミテッド 複数のミニカプセルの製造
US20100239665A1 (en) * 2007-05-01 2010-09-23 Ivan Coulter Pharmaceutical nimodipine compositions
DK2180787T3 (da) 2007-08-01 2014-02-03 Univ Pittsburgh Nitrooliesyremodulering af type ii-diabetes
BRPI0816507A2 (pt) * 2007-10-17 2014-10-07 Unilever Nv "produto comestível, processo para a preparação de uma cápsula revestida e uso de um produto comestível"
NZ600720A (en) * 2008-01-10 2012-12-21 Takeda Pharmaceutical A Seamless Capsule For A Liquid Pharmaceutical Composition
EP2280928B1 (de) 2008-05-01 2018-07-25 Complexa Inc. Vinylsubstituierte fettsäuren
CN102099024B (zh) 2008-06-19 2015-11-25 犹他大学研究基金会 硝化脂质在毒性医疗疗法的副作用的治疗上的用途
US20140024713A1 (en) 2008-06-19 2014-01-23 University Of Utah Research Foundation Use of nitrated lipids for treatment of side effects of toxic medical therapies
EP4137128A1 (de) 2008-09-02 2023-02-22 Amarin Pharmaceuticals Ireland Limited Pharmazeutische zusammensetzungen mit eicosapentaensäure und nikotinsäure und verfahren zur verwendung davon
US20100062057A1 (en) * 2008-09-10 2010-03-11 Pronova BioPharma Norge AS. Formulation
US20100130608A1 (en) * 2008-10-01 2010-05-27 Martek Biosciences Corporation Compositions and methods for reducing triglyceride levels
PT2395991E (pt) 2009-02-10 2013-09-03 Amarin Pharmaceuticals Ie Ltd Utilização de éster etílico de ácido eicosapentaenóico para tratamento de hipertrigliceridemia
JP2010184913A (ja) * 2009-02-13 2010-08-26 Freunt Ind Co Ltd 微生物または生物由来物質含有微細粒子およびその製造方法
US8207363B2 (en) 2009-03-19 2012-06-26 Martek Biosciences Corporation Thraustochytrids, fatty acid compositions, and methods of making and uses thereof
EP3791880A1 (de) 2009-04-29 2021-03-17 Amarin Pharmaceuticals Ireland Limited Pharmazeutische zusammensetzungen enthaltend epa
LT3278665T (lt) 2009-04-29 2020-12-10 Amarin Pharmaceuticals Ireland Limited Stabili farmacinė kompozicija ir jos panaudojimo būdai
WO2010133609A2 (en) 2009-05-18 2010-11-25 Sigmoid Pharma Limited Composition comprising oil drops
ES2856959T3 (es) 2009-06-15 2021-09-28 Amarin Pharmaceuticals Ie Ltd Composiciones y métodos para el tratamiento del ictus en un sujeto en terapia simultánea con estatina
CA2769624C (en) 2009-07-31 2018-09-11 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Electrophilic fatty acid derivatives as anti-inflammatory agents
CN102573802A (zh) 2009-08-12 2012-07-11 希格默伊德药业有限公司 包含聚合物基质和油相的免疫调节组合物
RU2012116079A (ru) 2009-09-23 2013-10-27 АМАРИН КОРПОРЕЙШН ПиЭлСи Фармацевтическая композиция, включающая омега-3 жирную кислоту и гидроксипроизводное статина и способы ее применения
US8686167B2 (en) 2009-10-02 2014-04-01 Complexa, Inc. Heteroatom containing substituted fatty acids
EP2490678B1 (de) * 2009-10-23 2021-08-04 Basf As Beschichtete kapseln und tabletten aus einer fettsäure-öl-mischung
KR20120133381A (ko) 2010-01-19 2012-12-10 디에스엠 아이피 어셋츠 비.브이. 에이코사펜타엔산 생산 미생물, 지방산 조성물 및 이의 제조방법 및 용도
EP2542060B1 (de) * 2010-03-04 2019-10-02 Amarin Pharmaceuticals Ireland Limited Zusammensetzungen zur behandlung und/oder prävention von herz-kreislauf-erkrankungen
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
US11712429B2 (en) 2010-11-29 2023-08-01 Amarin Pharmaceuticals Ireland Limited Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
US20140127289A1 (en) 2010-11-29 2014-05-08 Armarin Pharmaceuticals Ireland Limited Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
CN108771240A (zh) 2011-07-21 2018-11-09 帝斯曼知识产权资产管理有限公司 脂肪酸组合物
EP2744491B1 (de) 2011-08-19 2020-07-29 The University of Utah Research Foundation Kombinationstherapie mit nitrierten lipiden und inhibitoren des renin-angiotensin-aldosteron-systems
US11291643B2 (en) 2011-11-07 2022-04-05 Amarin Pharmaceuticals Ireland Limited Methods of treating hypertriglyceridemia
US20130131170A1 (en) 2011-11-07 2013-05-23 Amarin Pharmaceuticals Ireland Limited Methods of treating hypertriglyceridemia
EP2800469B1 (de) 2012-01-06 2021-08-25 Amarin Pharmaceuticals Ireland Limited Zusammensetzungen und verfahren zur senkung der konzentration an hochsensitivem c-reaktiven protein (hs-crp) bei einer person
DK3363433T3 (da) 2012-06-29 2021-03-08 Amarin Pharmaceuticals Ie Ltd Fremgangsmåder til reduktion af risikoen for en kardiovaskulær begivenhed i et individ i statinbehandling ved anvendelse af eicosapentaensyreetylester
GB201212010D0 (en) 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
PT2885005T (pt) * 2012-08-20 2018-01-03 Merck Patent Gmbh Preparação farmacêutica sólida contendo levotiroxina
US20150265566A1 (en) 2012-11-06 2015-09-24 Amarin Pharmaceuticals Ireland Limited Compositions and Methods for Lowering Triglycerides without Raising LDL-C Levels in a Subject on Concomitant Statin Therapy
US9814733B2 (en) 2012-12-31 2017-11-14 A,arin Pharmaceuticals Ireland Limited Compositions comprising EPA and obeticholic acid and methods of use thereof
US20140187633A1 (en) 2012-12-31 2014-07-03 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis
US9452151B2 (en) 2013-02-06 2016-09-27 Amarin Pharmaceuticals Ireland Limited Methods of reducing apolipoprotein C-III
US9624492B2 (en) 2013-02-13 2017-04-18 Amarin Pharmaceuticals Ireland Limited Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof
US9662307B2 (en) 2013-02-19 2017-05-30 The Regents Of The University Of Colorado Compositions comprising eicosapentaenoic acid and a hydroxyl compound and methods of use thereof
US9283201B2 (en) 2013-03-14 2016-03-15 Amarin Pharmaceuticals Ireland Limited Compositions and methods for treating or preventing obesity in a subject in need thereof
US20140271841A1 (en) 2013-03-15 2014-09-18 Amarin Pharmaceuticals Ireland Limited Pharmaceutical composition comprising eicosapentaenoic acid and derivatives thereof and a statin
US10966968B2 (en) 2013-06-06 2021-04-06 Amarin Pharmaceuticals Ireland Limited Co-administration of rosiglitazone and eicosapentaenoic acid or a derivative thereof
US20150065572A1 (en) 2013-09-04 2015-03-05 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing prostate cancer
US9585859B2 (en) 2013-10-10 2017-03-07 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
WO2015060313A1 (ja) * 2013-10-22 2015-04-30 森下仁丹株式会社 放出制御能を有する製剤およびその製造方法
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
US10561631B2 (en) 2014-06-11 2020-02-18 Amarin Pharmaceuticals Ireland Limited Methods of reducing RLP-C
US10172818B2 (en) 2014-06-16 2019-01-08 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
NZ729581A (en) * 2014-09-23 2023-05-26 Jost Chemical Co Fatty acid composition and method for fortifying nutritional products with fatty acids
BR112017009510A2 (pt) 2014-11-07 2017-12-19 Sigmoid Pharma Ltd composições compreendendo ciclosporina
US10513524B2 (en) 2015-07-07 2019-12-24 H. Lundbeck A/S PDE9 inhibitors with imidazo triazinone backbone and imidazo pyrazinone backbone for treatment of peripheral diseases
EP3346996A4 (de) * 2015-09-11 2019-04-17 Sun Pharmaceutical Industries Limited Orale pharmazeutische darreichungsformen von budesonid
BR112018006687A2 (pt) 2015-10-02 2018-10-09 Complexa Inc prevenção, tratamento e reversão de doenças utilizando montantes terapeuticamente eficazes de ácidos graxos ativos
US10406130B2 (en) 2016-03-15 2019-09-10 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
US10966951B2 (en) 2017-05-19 2021-04-06 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides in a subject having reduced kidney function
CN108264410A (zh) * 2018-03-01 2018-07-10 闫超 一种肥料用的双层微胶囊包被
US11058661B2 (en) 2018-03-02 2021-07-13 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy and having hsCRP levels of at least about 2 mg/L
CN117843645A (zh) 2018-05-25 2024-04-09 伊马拉公司 一种pde9抑制剂的一水合物和结晶形态
PT4056176T (pt) 2018-09-24 2024-05-27 Amarin Pharmaceuticals Ie Ltd Métodos de redução do risco de eventos cardiovasculares num indivíduo
CA3139731A1 (en) * 2019-06-14 2020-12-17 Takehiro Nishikawa Delayed disintegration-type capsule and method for producing same
KR20240012390A (ko) 2021-04-21 2024-01-29 애머린 파마슈티칼스 아일랜드 리미티드 심부전의 위험을 감소시키는 방법

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3224619A1 (de) * 1981-07-14 1983-05-19 Freund Industrial Co., Ltd., Tokyo Orale pharmazeutische zusammensetzung
JPS5939834A (ja) 1982-08-31 1984-03-05 Morishita Jintan Kk 製剤用皮膜組成物
US4422985A (en) * 1982-09-24 1983-12-27 Morishita Jintan Co., Ltd. Method and apparatus for encapsulation of a liquid or meltable solid material
US4849227A (en) * 1986-03-21 1989-07-18 Eurasiam Laboratories, Inc. Pharmaceutical compositions
JPH0774150B2 (ja) 1987-07-31 1995-08-09 新田ゼラチン株式会社 肝油用ソフトカプセル
JP2806564B2 (ja) * 1989-07-20 1998-09-30 森下仁丹株式会社 親水性物質を内容物とするシームレスカプセルおよびその製法
JPH04178321A (ja) * 1990-11-09 1992-06-25 Fuji Capsule Kk ゼラチンカプセル皮膜
JP3313124B2 (ja) * 1991-07-31 2002-08-12 森下仁丹株式会社 親水性物質を内容物とするシームレスカプセルおよびその製法
JPH0753356A (ja) * 1993-08-16 1995-02-28 Morishita Jintan Kk 酸化され易い油性物質を内容物とするシームレスカプセルおよびその製造方法
JP2506048B2 (ja) 1993-08-27 1996-06-12 花王株式会社 カプセル含有浴用剤組成物
GB2290965A (en) * 1994-07-11 1996-01-17 Therapicon Srl Multiple layer capsules for drugs
GB9509764D0 (en) * 1995-05-15 1995-07-05 Tillotts Pharma Ag Treatment of inflammatory bowel disease using oral dosage forms of omega-3 polyunsaturated acids

Also Published As

Publication number Publication date
JP4309045B2 (ja) 2009-08-05
EP1025842A1 (de) 2000-08-09
US6531150B1 (en) 2003-03-11
KR100569319B1 (ko) 2006-04-07
CA2307776A1 (en) 1999-05-14
KR20010031594A (ko) 2001-04-16
WO1999022719A1 (fr) 1999-05-14
EP1025842B1 (de) 2004-07-21
DE69825173T2 (de) 2005-08-25
CA2307776C (en) 2008-01-15
EP1025842A4 (de) 2003-03-05

Similar Documents

Publication Publication Date Title
DE69825173D1 (de) Doppelschichtige kapsel von ungesättigten fettsäuren oder deren derivate und verfahren zu deren herstellung
DE69501872T2 (de) Wässrige fluorpolymeremulsion und verfahren zu dessen herstellung
DE69907443D1 (de) Fettprodukte von sojaöl mit hohem stearinsäuregehalt und verfahren zu deren herstellung
ATE307576T1 (de) Fenofibrathaltige arzneizusammensetzung mit erhöhter bioverfügbarkeit und verfahren zu deren herstellung
DE69616516D1 (de) Wasserschutzzusammensetzungen und verfahren zu deren herstellung
DE3581328D1 (de) Derivate des menschlichen alpha-1-antitrypins und verfahren zu deren herstellung.
DE69608359T2 (de) Hexaazaisowurtzitan-derivate und verfahren zu deren herstellung
DE59905405D1 (de) Verfahren zur Herstellung von Chinolon-und Naphthyridoncarbonsäuren und deren Ester
DE69738570D1 (de) Konzentrierte wässerige tensidzusammensetzungen von betaintyp und verfahren zu deren herstellung
ATA75297A (de) Dekorlaminat und verfahren zu seiner herstellung
DE69405502T2 (de) Verfahren zur herstellung von 2-fluor isobuttersäure und deren ester
DE69725323D1 (de) Biomedizinische elektrode und verfahren zu deren herstellung
DE69410994D1 (de) Verfahren zur herstellung von chinolincarbonsäuren und deren derivate
DE59605951D1 (de) Verfahren zur kontinuierlichen herstellung von n-acylaminocarbonsäuren und n-acylaminosulfonsäuren sowie deren alkalimetallsalzen
DE59504636D1 (de) Verfaharen zur herstellung von carboxy-arensulfonsäuren und deren carbonsäurederivaten
DE59502926D1 (de) Verfahren zur herstellung von alkaliaminoborhydriden und alkaliaminoborhydrid-komplexen
DE69519388T2 (de) Verfahren zur herstellung von 2-(omega-alkoxycarbonylalkanoyl)-4-butanolid und langkettiger omega-hydroxycarbonsäure
ATA73198A (de) Verfahren zur herstellung von pfählen und solchermassen hergestellte pfähle
DE59700696D1 (de) Verfahren und zwischenprodukte zur herstellung von pyridyl-4-fluoranilinen
DE69716962D1 (de) Verfahren zur herstellung von substituierten trifluorobenzoesäurederivaten und deren ester
DE69422953D1 (de) Verfahren zur Herstellung von D-Milchsäure und L-Lactamid
DE69600338D1 (de) Verfahren zur Herstellung von Naphthalin-2,6-dicarbonsäure und ihrem Ester
DE69521031D1 (de) Verfahren und vorrichtung zum unterstützen der herstellung von bewegtbilder-cd-rom-software
DE69805744T2 (de) Verfahren zur Herstellung von alpha-Aminonitrilen und alpha-Aminosäuren
DE59607845D1 (de) Verfahren zur herstellung von bis-alkoxy-triazinyl-aminohaltigen stilben-disulfonsäuren oder deren derivate

Legal Events

Date Code Title Description
8364 No opposition during term of opposition